ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

VSGN Vasogen (MM)

0.264
0.00 (0.00%)
22 Nov 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Vasogen (MM) NASDAQ:VSGN NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.264 0 00:00:00

- Report of Foreign Issuer (6-K)

06/10/2009 11:02am

Edgar (US Regulatory)


 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO SECTION 13a-16 OR 15d-16 OF THE

SECURITIES EXCHANGE ACT OF 1934

 

For the month of October 2009

 

Commission File Number: 0-29350

 

VASOGEN INC.

(Translation of registrant’s name into English)

 

4 ROBERT SPECK PARKWAY, 15 TH FLOOR
MISSISSAUGA, ONTARIO L4Z 1S1

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F     x

Form 40-F  [_]

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1). ____

 

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

 

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

 

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes ___________

No      x

 

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-______ .

 

 

 


EXHIBIT LIST

 

 

Exhibit

 

Title

 

 

 

99.1

 

A Letter of Confirmation, dated September 28, 2009, from CIBC Mellon Trust Company, to each of the securities commission or equivalent authority of Canada's thirteen provinces and territories, stating that the proxy, the notice of meeting/information circular and the letter of transmittal for Vasogen Inc. have been sent to all registered shareholders of Vasogen Inc., as filed with CSA on October 5, 2009

 

 

 

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

 

VASOGEN INC.
(Registrant)

 

 

By: 



/s/ Graham Neil



Date: October 5, 2009

 

 

Name: Graham Neil
Title: Vice President, Finance and
Chief Financial Officer

 

 


EXHIBIT INDEX

 

 

Exhibit

 

Title

 

 

 

99.1

 

A Letter of Confirmation, dated September 28, 2009, from CIBC Mellon Trust Company, to each of the securities commission or equivalent authority of Canada's thirteen provinces and territories, stating that the proxy, the notice of meeting/information circular and the letter of transmittal for Vasogen Inc. have been sent to all registered shareholders of Vasogen Inc., as filed with CSA on October 5, 2009

 

 

 

 

 

 

 

 

 

 

1 Year Vasogen Chart

1 Year Vasogen Chart

1 Month Vasogen Chart

1 Month Vasogen Chart

Your Recent History

Delayed Upgrade Clock